Policy of making cutting-edge technology R&D the core of the business
First written in FY2016. 34 of 35 entries say "Restated". Latest entry: FY2026-H1.
96 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「During the interim accounting period, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the interim accounting period increased by ¥15 million, or 9.5%, year on year, to ¥182 million.」
There were no material changes to, or newly initiated activities in, R&D, while R&D expenses increased 9.5% year on year to ¥182 million. - FY2025RestatedAnnual report
「We are engaged in research and development and continuously conduct R&D into cutting-edge technologies as a core business activity.」
The policy of making R&D a core business activity was reconfirmed, and R&D expenses for the fiscal year reached ¥363 million. - FY2025-H1RestatedAnnual report
「During the interim accounting period, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the interim accounting period increased by ¥6 million, or 4.0%, year on year, to ¥166 million.」
There were no material changes to, or newly initiated activities in, R&D, and R&D expenses were ¥166 million, up 4.0% year on year. - FY2024RestatedAnnual report
「We are engaged in research and development and continuously conduct R&D into cutting-edge technologies as a core business activity.」
The policy of making R&D a core business activity was reconfirmed, and R&D expenses for the fiscal year were ¥320 million. - FY2024-Q3RestatedAnnual report
「During the cumulative third quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative third quarter increased by ¥0 million, or 0.3%, year on year, to ¥237 million.」
There were no material changes to, or newly initiated activities in, R&D, and R&D expenses were ¥237 million, up 0.3% year on year. - FY2024-Q2RestatedAnnual report
「During the cumulative second quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative second quarter increased by ¥4 million, or 2.9%, year on year, to ¥160 million.」
There were no material changes to, or newly initiated activities in, R&D, and R&D expenses reached ¥160 million. - FY2024-Q1RestatedAnnual report
「During the cumulative first quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative first quarter decreased by ¥2 million, or 3.0%, year on year, to ¥81 million.」
There were no material changes to the policy of continuing R&D, and R&D expenses were ¥81 million. - FY2023RestatedAnnual report
「We are engaged in research and development and continuously conduct R&D into cutting-edge technologies as a core business activity.」
The policy of making R&D a core business activity was reconfirmed, and R&D expenses for the fiscal year were ¥325 million. - FY2023-Q3RestatedAnnual report
「During the cumulative third quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative third quarter decreased by ¥13 million, or 5.4%, year on year, to ¥236 million.」
There were no material changes to R&D activities, and R&D expenses were ¥236 million, down 5.4% year on year. - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative second quarter decreased by ¥18 million, or 10.7%, year on year, to ¥155 million.」
There were no material changes to, or newly initiated activities in, R&D, and R&D expenses were ¥155 million. - FY2023-Q1RestatedAnnual report
「During the cumulative first quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative first quarter decreased by ¥10 million, or 11.4%, year on year, to ¥84 million.」
There were no material changes to the policy of continuing R&D, and R&D expenses were ¥84 million. - FY2022RestatedAnnual report
「We are engaged in research and development and continuously conduct R&D into cutting-edge technologies as a core business activity.」
The policy of continuing to make R&D a core business activity was reconfirmed, and R&D expenses for the fiscal year were ¥334 million. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative third quarter increased by ¥36 million, or 17.2%, year on year, to ¥249 million.」
There were no material changes to, or newly initiated activities in, R&D, while R&D expenses increased 17.2% year on year to ¥249 million. - FY2022-Q2RestatedAnnual report
「During the cumulative second quarter, there were no material changes to, or newly initiated activities in, our research and development activities.」
There were no material changes to R&D activities, and R&D expenses were ¥174 million, up 27.0% year on year. - FY2022-Q1RestatedAnnual report
「During the cumulative first quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative first quarter increased by ¥28 million, or 42.4%, year on year, to ¥94 million.」
There were no material changes to the policy of making R&D a core business activity, and R&D expenses reached ¥94 million. - FY2021RestatedAnnual report
「We are engaged in research and development and continuously conduct R&D into cutting-edge technologies as a core business activity.」
The policy of making R&D a core business activity was reconfirmed, and R&D expenses for the fiscal year were ¥288 million. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative third quarter increased by ¥32 million, or 18.0%, year on year, to ¥213 million.」
There were no material changes to, or newly initiated activities in, R&D, while R&D expenses increased 18.0% year on year to ¥213 million. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative second quarter increased by ¥22 million, or 19.6%, year on year, to ¥137 million.」
There were no material changes to, or newly initiated activities in, R&D, while R&D expenses increased 19.6% year on year to ¥137 million. - FY2021-Q1RestatedAnnual report
「During the cumulative first quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative first quarter increased by ¥8 million, or 13.8%, year on year, to ¥66 million.」
There were no material changes to the policy of making R&D a core business activity, and R&D expenses rose 13.8% year on year to ¥66 million. - FY2020RestatedAnnual report
「We are engaged in research and development and continuously conduct R&D into cutting-edge technologies as a core business activity.」
The policy of making R&D a core business activity was reconfirmed, and R&D expenses for the fiscal year were ¥246 million. - FY2020-Q3RestatedAnnual report
「During the cumulative third quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative third quarter decreased by ¥26 million, or 13.0%, year on year, to ¥180 million.」
There were no material changes to the policy of continuing R&D, and R&D expenses were ¥180 million. - FY2020-Q2RestatedAnnual report
「During the cumulative second quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative second quarter decreased by ¥34 million, or 23.0%, year on year, to ¥114 million.」
There were no material changes to R&D activities, and R&D expenses were ¥114 million, down 23.0% year on year. - FY2020-Q1RestatedAnnual report
「During the cumulative first quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative first quarter decreased by ¥23 million, or 28.4%, year on year, to ¥58 million.」
There were no material changes to the policy of continuing R&D. R&D expenses were ¥58 million, down 28.4% year on year. - FY2019-Q3RestatedAnnual report
「During the cumulative third quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative third quarter increased by ¥29 million, or 16.6%, year on year, to ¥207 million.」
There were no material changes to R&D activities, and R&D expenses rose 16.6% year on year to ¥207 million. - FY2019-Q2RestatedAnnual report
「During the cumulative second quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative second quarter increased by ¥30 million, or 25.4%, year on year, to ¥149 million.」
There were no material changes to R&D activities, and R&D expenses reached ¥149 million. - FY2019-Q1RestatedAnnual report
「During the cumulative first quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative first quarter increased by ¥21 million, or 34.5%, year on year, to ¥81 million.」
There were no material changes to the policy of making R&D a core activity, and R&D expenses increased 34.5% year on year to ¥81 million. - FY2018RestatedAnnual report
「We are engaged in research and development and continuously conduct R&D into cutting-edge technologies as a core business activity.」
The policy of making R&D a core business activity was reconfirmed, and R&D expenses for the fiscal year were ¥244 million. - FY2018-Q3RestatedAnnual report
「During the cumulative third quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative third quarter decreased by ¥3 million, or 2.0%, year on year, to ¥178 million.」
There were no material changes to R&D activities, and ¥178 million in R&D expenses was recorded. - FY2018-Q2RestatedAnnual report
「During the cumulative second quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative second quarter decreased by ¥0.5 million, or 0.5%, year on year, to ¥118 million.」
There were no material changes to R&D activities, and R&D expenses were ¥118 million. - FY2018-Q1RestatedAnnual report
「During the cumulative first quarter, there were no material changes to, or newly initiated activities in, our research and development activities. Total R&D expenses for the cumulative first quarter increased by ¥0.5 million, or 0.9%, year on year, to ¥60 million.」
There were no material changes to R&D activities, and ¥60 million in R&D expenses was recorded. - FY2017RestatedAnnual report
「We are engaged in research and development and continuously conduct R&D into cutting-edge technologies as a core business activity.」
The policy of making R&D the core of the business was reaffirmed, and R&D expenses for the fiscal year were ¥240 million. - FY2017-Q3RestatedAnnual report
「During the cumulative third quarter, there were no significant changes in, or newly initiated activities related to, our research and development activities. Total R&D expenses for the cumulative third quarter were ¥181 million.」
There were no significant changes in R&D activities, and R&D expenses of ¥181 million were recorded. - FY2017-Q2RestatedAnnual report
「During the cumulative second quarter, there were no significant changes in, or newly initiated activities related to, our research and development activities. Total R&D expenses for the cumulative second quarter were ¥119 million.」
R&D activities continued, with R&D expenses of ¥119 million recorded for the cumulative second quarter. - FY2017-Q1RestatedAnnual report
「During the cumulative first quarter, there were no significant changes in, or newly initiated activities related to, our research and development activities. Total R&D expenses for the cumulative first quarter were ¥60 million.」
The continuation of R&D activities was confirmed. - FY2016First statedAnnual report
「Our corporate group is engaged in research and development and continuously conducts R&D into cutting-edge technologies as a core business activity.」
¥200 million was spent on R&D during the fiscal year.